Alerts will be sent to your verified email
Verify EmailBACPHAR
Bacil Pharma
|
Shelter Pharma
|
Sandu Pharmaceutical
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-73.86 % | 15.08 % | 3.94 % |
5yr average Equity Multiplier
|
1.72 | 1.38 | 1.34 |
5yr Average Asset Turnover Ratio
|
0.0 | 2.02 | 1.27 |
5yr Avg Net Profit Margin
|
0.0 | 7.29 % | 2.31 % |
Price to Book
|
29.01 | 0.0 | 1.27 |
P/E
|
141.3 | 7.71 | 35.2 |
5yr Avg Cash Conversion Cycle
|
0.0 | 151.86 Days | 27.73 Days |
Inventory Days
|
0.0 | 65.6 Days | 71.51 Days |
Days Receivable
|
0.0 | 77.72 Days | 26.2 Days |
Days Payable
|
23.71 Days | 5.04 Days | 79.23 Days |
5yr Average Interest Coverage Ratio
|
-950.16 | 71.95 | 28.27 |
5yr Avg ROCE
|
-81.01 % | 21.3 % | 5.77 % |
5yr Avg Operating Profit Margin
|
0.0 | 11.0 % | 3.87 % |
5 yr average Debt to Equity
|
0.08 | 0.04 | 0.0 |
5yr CAGR Net Profit
|
-28.45 % | 138.7 % | -1.69 % |
5yr Average Return on Assets
|
-72.13 % | 11.22 % | 2.94 % |
Shareholdings
|
|||
Promoter Holding
|
0.2 % | 52.32 % | 42.9 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-42.47 % | -4.57 % | -7.53 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Bacil Pharma
|
Shelter Pharma
|
Sandu Pharmaceutical
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|